Company attributes
Other attributes
EpiVax is a Rhode Island-based immunology company dedicated to applying its tools (in-silico, in-vitro, and in-vivo) to re-engineering therapeutic proteins and to designing new vaccines.The company has various offerings, such as vaccine services, immunogenicity assessment, deimmunizaiton, laboratory services, and pipeline services.
The company has been developing a peptide-based, epitope-driven vaccine candidate for healthcare workers who are working during the COVID-19 pandemic. It has partnered with the GAIA Vaccine Foundation (GVF). The two entities are crowd-sourcing the funds and have pledged to make a free license available to developing countries who qualify for it.
The company's research is being conducted in conjunction with researchers at the University of Georgia's Center for Vaccines and Immunology.
